Making risk statements stick

Vox Sanguinis

Volumn 83, Issue 3, 2002, Pages 199-203

  Dumont, Larry J ^a   AuBuchon, J P ^b  

^a Gambro BCT   (United States)

^b DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

THROMBOCYTE CONCENTRATE;

BLOOD TRANSFUSION; DATA ANALYSIS; DISEASE TRANSMISSION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; SEPSIS; VALIDATION PROCESS; VIRUS TRANSMISSION;

BLOOD TRANSFUSION; HEMOLYSIS; HUMANS; INCIDENCE; INFECTION; RISK ASSESSMENT; RISK MANAGEMENT;

EID: 0037715089     PISSN: 00429007     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1423-0410.2002.00233.x     Document Type: Review

References (16)

1. Simmonds P, Kurtz J, Tedder RS: The UK blood transfusion service: over a (patent) barrel? Lancet 2002; 359:1713-1714
2. AuBuchon JP, Cooper L, Leach MF, Zuaro DE, Schwartzman JD: Experience with Universal Bacterial Culturing to Detect Contamination of Apheresis Platelet Units in a Hospital Transfusion Service. Transfusion 2002; 42:855-861
3. Dodd RY, Aberle-Grasse JM, Stramer SL, Program A: The yield of nucleic acid testing (NAT) for HIV and HCV RNA in a population of U.S. voluntary blood donors: Relationship to contemporary measures of incidence. Transfusion 2000; 40:1S
4. Strainer SL, Peoples BG, Preston SB, Tzeng J, Davis J, Waldman KJ: Follow-up study of donors testing nucleic acid test (NAT) reactive for HIV or HCV. Transfusion 2000; 40:3S (abstract)
5. Busch MP., Lee LL, Satten GA, Henrard DR, Farzadegan H, Nelson KE, Read S, Dodd RY, Petersen LR: Time course for detection of viral and serologic markers preceding human immunodeficiency virus type 1 seroconversion: Implications for screening of blood and tissue donors. Transfusion 1995; 35:91-97
6. AuBuchon JP, Birkmeyer JD, Busch MP: Cost-effectiveness of expanded human immunodeficiency virus-testing protocols for donated blood. Transfusion 1997; 37:45-51
7. Ness P, Braine H, King K, Barrasso C, Kickler T, Fuller A, Blades N: Single-donor platelets reduce the risk of septic platelet transfusion reactions. Transfusion 2001; 41:857-861
8. Perez P, Salmi LR, Folléa G, Schmit J-L, de Barbeyrac B, Sudre P, Salamon R: Determinants of transfusion-associated bacterial contamination: results of the French Bacthem Case-Control Study. Transfusion 2001; 41:862-872
9. Sackett DL, Staus SE, Richardson WS, Rosenberg W, Haynes RB: Evidence-Based Medicine. How to Practice and Teach EBM. 2nd edn, Edinburgh, Churchill Livingstone, 2000
10. Dyskstra A, Jacob J, Yomtovian R: Prospective microbiological surveillance (PMS) of random donor (RDP) and single donor apheresis platelets (SDP) (Abstract). Transfusion 1998; 38:104S
11. AuBuchon JP: The role of decision analysis in transfusion medicine. Vox Sang 1996; 71:1-5
12. AuBuchon JP, Birkmeyer Busch MP: Blood Safety: Challenges and opportunities. Ann Int Med 1997; 127:904-909
13. AuBuchon JP: Making decisions to improve transfusion safety; in Stramer SL [ed.): Blood Safety in the New Millennium. Bethesda, American Association of Blood Banks, 2001
14. Linden JV, Paul B, Dressler KP: A report of 104 transfusion errors in New York State. Transfusion 1992; 32:601-606
15. Wenz B, Burns ER: Improvement in transfusion safety using a new blood unit and patient identification system as part of safe transfusion practice. Transfusion 1991; 31:401-403
16. Jensen NJ, Crosson JT: An automated system for bedside verification of the match between patient identification and blood unit identification. Transfusion 1996; 36:216-221